Using the weighted area under the net benefit curve for decision curve analysis

Supplementary Material.docx. Includes the Appendix and two supplementary figures referred in the manuscript. (DOCX 327 kb

A powerful hybrid approach to select top single-nucleotide polymorphisms for genome-wide association study

<p>Abstract</p> <p>Background</p> <p>Genome-wide association (GWA) study has recently become a powerful approach for detecting genetic variants for common diseases without prior knowledge of the variant's location or function. Generally, in GWA studies, the most significant single-nucleotide polymorphisms (SNPs) associated with top-ranked p values are selected in stage one, with follow-up in stage two. The value of selecting SNPs based on statistically significant p values is obvious. However, when minor allele frequencies (MAFs) are relatively low, less-significant p values can still correspond to higher odds ratios (ORs), which might be more useful for prediction of disease status. Therefore, if SNPs are selected using an approach based only on significant p values, some important genetic variants might be missed. We proposed a hybrid approach for selecting candidate SNPs from the discovery stage of GWA study, based on both p values and ORs, and conducted a simulation study to demonstrate the performance of our approach.</p> <p>Results</p> <p>The simulation results showed that our hybrid ranking approach was more powerful than the existing ranked p value approach for identifying relatively less-common SNPs. Meanwhile, the type I error probabilities of the hybrid approach is well-controlled at the end of the second stage of the two-stage GWA study.</p> <p>Conclusions</p> <p>In GWA studies, SNPs should be considered for inclusion based not only on ranked p values but also on ranked ORs.</p

Genetic imprinting analysis for alcoholism genes using variance components approach

Genomic imprinting, which is also known as the parent-of-origin effect, is a mechanism that only expresses one copy of a gene pair depending upon the parental origin. Although many chromosomal regions in the human genome are likely to be imprinted, imprinting is not accounted for in the usual linkage analysis. In this study, using a variance-components approach with a quantitative phenotype ttth-FP1, we found significant evidence of imprinting at two loci, D7S1790 and D1S1631, on chromosome 1 and chromosome 7, respectively. Our results suggest that allowing for the possibility of imprinting can increase the power to detect linkage for localizing genes for alcoholism

Analysis of alcoholism data using support vector machines

A supervised learning method, support vector machine, was used to analyze the microsatellite marker dataset of the Collaborative Study on the Genetics of Alcoholism Problem 1 for the Genetic Analysis Workshop 14. Twelve binary-valued phenotype variables were chosen for analyses using the markers from all autosomal chromosomes. Using various polynomial kernel functions of the support vector machine and randomly divided genome regions, we were able to observe the association of some marker sets with the chosen phenotypes and thus reduce the size of the dataset. The successful classifications established with the chosen support vector machine kernel function had high levels of correctness for each prediction, e.g., 96% in the fourfold cross-validations. However, owing to the limited sample data, we were not able to test the predictions of the classifiers in the new sample data

Analysis of genes for alcoholism using two-disease-locus models

Using model-based two-locus methods for mapping genes, we analyzed the family data from the Collaborative Study on the Genetics of Alcoholism. Microsatellite data from 143 families ascertained through having three or more individuals affected with alcohol dependence were used for this investigation. Four regions showing evidence for linkage were identified using single-locus models from previous investigations. We investigated the genetic linkage, pattern of disease inheritance, and pair-wise genetic epistasis of these loci using the TLINKAGE program for two-disease-locus analysis

Comparison of multilevel modeling and the family-based association test for identifying genetic variants associated with systolic and diastolic blood pressure using Genetic Analysis Workshop 18 simulated data

Identifying genetic variants associated with complex diseases is an important task in genetic research. Although association studies based on unrelated individuals (ie, case-control genome-wide association studies) have successfully identified common single-nucleotide polymorphisms for many complex diseases, these studies are not so likely to identify rare genetic variants. In contrast, family-based association studies are particularly useful for identifying rare-variant associations. Recently, there has been some interest in employing multilevel models in family-based genetic association studies. However, the performance of such models in these studies, especially for longitudinal family-based sequence data, has not been fully investigated. Therefore, in this study, we investigated the performance of the multilevel model in the family-based genetic association analysis and compared it with the conventional family-based association test, by examining the powers and type I error rates of the 2 approaches using 3 data sets from the Genetic Analysis Workshop 18 simulated data: genome-wide association single-nucleotide polymorphism data, sequence data, and rare-variants-only data. Compared with the univariate family-based association test, the multilevel model had slightly higher power to identify most of the causal genetic variants using the genome-wide association single-nucleotide polymorphism data and sequence data. However, both approaches had low power to identify most of the causal single-nucleotide polymorphisms, especially those among the relatively rare genetic variants. Therefore, we suggest a unified method that combines both approaches and incorporates collapsing strategy, which may be more powerful than either approach alone for studying genetic associations using family-based data

Testing Hardy-Weinberg Proportions in a Frequency-Matched Case-Control Genetic Association Study

In case-control genetic association studies, cases are subjects with the disease and controls are subjects without the disease. At the time of case-control data collection, information about secondary phenotypes is also collected. In addition to studies of primary diseases, there has been some interest in studying genetic variants associated with secondary phenotypes. In genetic association studies, the deviation from Hardy-Weinberg proportion (HWP) of each genetic marker is assessed as an initial quality check to identify questionable genotypes. Generally, HWP tests are performed based on the controls for the primary disease or secondary phenotype. However, when the disease or phenotype of interest is common, the controls do not represent the general population. Therefore, using only controls for testing HWP can result in a highly inflated type I error rate for the disease- and/or phenotype-associated variants. Recently, two approaches, the likelihood ratio test (LRT) approach and the mixture HWP (mHWP) exact test were proposed for testing HWP in samples from case-control studies. Here, we show that these two approaches result in inflated type I error rates and could lead to the removal from further analysis of potential causal genetic variants associated with the primary disease and/or secondary phenotype when the study of primary disease is frequency-matched on the secondary phenotype. Therefore, we proposed alternative approaches, which extend the LRT and mHWP approaches, for assessing HWP that account for frequency matching. The goal was to maintain more (possible causative) single-nucleotide polymorphisms in the sample for further analysis. Our simulation results showed that both extended approaches could control type I error probabilities. We also applied the proposed approaches to test HWP for SNPs from a genome-wide association study of lung cancer that was frequency-matched on smoking status and found that the proposed approaches can keep more genetic variants for association studies

Pharmacokinetic availability of proteolytic enzymes after oral administration: a narrative review of the literature

Orally administered serine and cysteine proteolytic enzymes are used extensively in the therapy of various inflammatory conditions. However, due to their protein nature, there have been concerns about these enzymes undergoing digestion or biotransformation in the gut and the resultant amount of active enzyme reaching blood circulation and at the site of inflammation. Research has shown that orally administered serine and cysteine proteases are able to pass through the mucosal barrier of the gastrointestinal tract and reach the blood and lymph as intact, high molecular weight and physiologically active forms. These have been studied in in vitro, animal models and further confirmed in human studies. Despite high inter-individual variability, the maximum plasma levels of the free proteases follow dose linearity. They circulate bound to plasma anti-proteases and are detectable in clinically significant concentrations. Targeted studies also indicate that paracellular transport mechanism may play a significant role in the absorption of these molecules. We present a summary of the existing knowledge from these studies